All Stories

  1. Considerations for nanoscale drug-delivery systems for the cornea
  2. Endothelial–perivascular mural partitioning and multicellular signaling in injury-associated corneal neovascularization
  3. Pirfenidone Inhibits Inflammatory Mediators in Human Cornea In Vitro
  4. Myogenic Differentiation (MyoD) Gene Expression in Cornea and Role in Corneal Myofibroblast Dedifferentiation
  5. ATAC-seq revealing chromatin accessibility and novel motifs linked to corneal fibrosis
  6. Long-Term Tolerability and Safety of AAV5 -Id3 Gene Therapy to Eyes
  7. Alterations in Mitochondrial DNA in Corneal Fibroblast and Myofibroblast Post Injury
  8. Endothelial–perivascular mural partitioning and multicellular signaling in trauma-associated corneal neovascularization
  9. Identification of dysregulated gene clusters and pathways driving ocular surface squamous neoplasia progression
  10. Topical Rho-Associated Protein Kinase Inhibitor HA1077 Reduces Rabbit Corneal Fibrosis and Neovascularization in Vivo
  11. Enzyme classification integrating LSTM and Prot-BERT sequence encoding
  12. Current progress in research on ocular injury caused by exposure to vesicants
  13. Single-Cell Transcriptomics Shows Cellular Heterogeneity, Intercellular Communication, and Extracellular Matrix Remodeling in Corneal Fibrosis In Vivo
  14. Carbofuran Exposure Alters Autophagy Flux in Human Cornea In Vitro and Ex Vivo
  15. Open-Field Blast Injury Disrupts Corneal Gene Expression Linked to Ion Transport, Sensory Perception, and Neural Signaling
  16. Artificial intelligence derived grading of mustard gas induced corneal injury and opacity
  17. Mustard Gas Induced Corneal Injury Involves Ferroptosis and p38 MAPK Signaling
  18. Identification of Potential Necroptosis Inhibitors using Pharmacophore Model: An In-silico Approach
  19. Transcriptomic landscape of quiescent and proliferating human corneal stromal fibroblasts
  20. RNA-Seq Analysis Unraveling Novel Genes and Pathways Influencing Corneal Wound Healing
  21. Tissue-targeted and localized AAV5-DCN and AAV5-PEDF combination gene therapy abrogates corneal fibrosis and concurrent neovascularization in rabbit eyes in vivo
  22. Corneal Scarring
  23. Gene Therapy for Cornea, Conjunctiva, and Lacrimal Gland
  24. Differential gene expression and protein-protein interaction network profiling of sulfur mustard-exposed rabbit corneas employing RNA-seq data and bioinformatics tools
  25. Deep learning-based prediction model for diagnosing gastrointestinal diseases using endoscopy images
  26. Pathophysiology, Current Therapeutic Options, Vaccine Candidates, and Drug Targets for Human Brucellosis
  27. Computational analysis of spike protein of SARS-CoV-2 (Omicron variant) for development of peptide-based therapeutics and diagnostics
  28. Corneal gene therapy: Structural and mechanistic understanding
  29. Artificial intelligence in intestinal polyp and colorectal cancer prediction
  30. Investigating molecular features that influence blood − brain barrier permeability of compounds
  31. Neuronal Vulnerability to Degeneration in Parkinson’s Disease and Therapeutic Approaches
  32. Unlocking the microbial studies through computational approaches: how far have we reached?
  33. Smelling the Disease: Diagnostic Potential of Breath Analysis
  34. Ligand-based Pharmacophore Modeling, Molecular Docking and Simulation Studies for the Exploration of Natural Potent Antiangiogenic Inhibitors Targeting Heat Shock Protein 90
  35. Artificial Intelligence in De novo Drug Design: Are We Still There?
  36. Developing human olfactory network and exploring olfactory receptor-odorant interaction
  37. Recent Applications of Artificial Intelligence in Early Cancer Detection
  38. Decoding seven basic odors by investigating pharmacophores and molecular features of odorants
  39. DeePred-BBB: A Blood Brain Barrier Permeability Prediction Model With Improved Accuracy
  40. Epigenetic Modifications by Estrogen and Androgen in Alzheimer’s Disease
  41. Screening of potential antigens from whole proteome and development of multi-epitope vaccine against Rhizopus delemar using immunoinformatics approaches
  42. DeepOlf: Deep Neural Network Based Architecture for Predicting Odorants and Their Interacting Olfactory Receptors
  43. Recent Applications of Artificial Intelligence in the Detection of Gastrointestinal, Hepatic and Pancreatic Diseases
  44. Crosstalk between epigenetics and mTOR as a gateway to new insights in pathophysiology and treatment of Alzheimer's disease
  45. OlfactionBase: a repository to explore odors, odorants, olfactory receptors and odorant–receptor interactions
  46. Deep Learning in Disease Diagnosis: Models and Datasets
  47. OBPred: feature-fusion-based deep neural network classifier for odorant-binding protein prediction
  48. Recent trends in stem cell-based therapies and applications of artificial intelligence in regenerative medicine
  49. Multi-Omics Approach in the Identification of Potential Therapeutic Biomolecule for COVID-19
  50. A deep neural network–based approach for prediction of mutagenicity of compounds
  51. Development of Machine Learning based blood-brain barrier permeability prediction models using physicochemical properties, MACCS and substructure fingerprints
  52. Hydroxychloroquine in COVID-19: therapeutic promises, current status, and environmental implications
  53. SMILES to Smell: Decoding the Structure–Odor Relationship of Chemical Compounds Using the Deep Neural Network Approach
  54. Dissecting Sex‐Related Cognition between Alzheimer’s Disease and Diabetes: From Molecular Mechanisms to Potential Therapeutic Strategies
  55. Available Compounds With Therapeutic Potential Against COVID-19: Antimicrobial Therapies, Supportive Care, and Probable Vaccines
  56. Therapeutic Promises of Chlorogenic Acid with Special Emphasis on its Anti-Obesity Property
  57. Blood Brain Barrier Permeability Prediction Using Machine Learning Techniques: An Update
  58. Sense of Smell: Structural, Functional, Mechanistic Advancements and Challenges in Human Olfactory Research
  59. Computational Outlook of Marine Compounds as Anti-Cancer Representatives Targeting BCL-2 and Survivin
  60. Prediction of Elimination of Compounds Using Artificial Intelligence Techniques
  61. Prediction of Drug-Plasma Protein Binding Using Artificial Intelligence Based Algorithms
  62. Promises of Machine Learning Approaches in Prediction of Absorption of Compounds
  63. Prediction of Human Intestinal Absorption of Compounds Using Artificial Intelligence Techniques
  64. Prediction of Metabolism of Drugs using Artificial Intelligence: How far have we reached?
  65. Can we predict blood brain barrier permeability of ligands using computational approaches?
  66. Prospects of Nano–Material in Breast Cancer Management
  67. Advanced stage of breast cancer hoist alkaline phosphatase activity: risk factor for females in India
  68. Brain Region Specific Monoamine and Oxidative Changes During Restraint Stress
  69. Novel Ocimumoside A and B as anti-stress agents: Modulation of brain monoamines and antioxidant systems in chronic unpredictable stress model in rats
  70. Application of microarray in breast cancer: An overview
  71. A comparative study of support vector machine, artificial neural network and Bayesian classifier for mutagenicity prediction
  72. Purification, Characterization, Sequencing and Biological Chemistry of Galectin-1 Purified from Capra hircus (goat) Heart
  73. A prediction model for oral bioavailability of drugs using physicochemical properties by support vector machine
  74. Stem cells: An overview with respect to cardiovascular and renal disease